Robeco Institutional Asset Management
IMCR icon

Robeco Institutional Asset Management’s Immunocore IMCR Stock Holding History

Robeco Institutional Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,324
Closed -$259K – 917
2024
Q3 		$259K Sell
8,324
-11,545
-58% -$420K ﹤0.01% 881
2024
Q2 		$673K Sell
19,869
-52,972
-73% -$2.7M ﹤0.01% 814
2024
Q1 		$4.73M Sell
72,841
-1,286
-2% -$88.3K 0.01% 558
2023
Q4 		$5.06M Buy
+74,127
New +$3.85M 0.01% 558
2023
Q2 		– Sell
-12,676
Closed -$627K – 1075
2023
Q1 		$627K Hold
12,676
– – ﹤0.01% 829
2022
Q4 		$723K Buy
+12,676
New +$713K ﹤0.01% 807

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Robeco Institutional Asset Management's IMCR Position: Q4 2024 in Review

Robeco Institutional Asset Management sold out of Immunocore (IMCR) in Q4 2024, closing a stake of 8,324 shares — an estimated $259K sold.

Robeco Institutional Asset Management first reported a position in IMCR in Q4 2022 and held it in 6 quarters. The position peaked at $5.06M in Q4 2023. 115 funds tracked by Wall St. Rank hold IMCR as of Q4 2024.

  • Robeco Institutional Asset Management reported no remaining Immunocore position as of Q4 2024 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 8,324 Immunocore shares in Q4 2024, an estimated $259K.
  • Robeco Institutional Asset Management first reported a position in Immunocore in Q4 2022 and held it in 6 quarters.
  • Robeco Institutional Asset Management's Immunocore position peaked at $5.06M in Q4 2023.
  • 115 funds tracked by Wall St. Rank held Immunocore as of Q4 2024.

Based on Robeco Institutional Asset Management's 13F filing for Q4 2024, filed 23 Jan 2025.